
HEALTHCARE TRUST OF AME-CL A (HTA) Fundamental Analysis & Valuation
NYSE:HTA • US42225P5017
Current stock price
29.19 USD
-0.02 (-0.07%)
At close:
29.23 USD
+0.04 (+0.14%)
After Hours:
This HTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HTA Profitability Analysis
1.1 Basic Checks
- In the past year HTA was profitable.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.38% | ||
| ROE | 2.94% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.13% | ||
| PM (TTM) | 12.13% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. HTA Health Analysis
2.1 Basic Checks
- HTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, HTA has more shares outstanding
- HTA has a better debt/assets ratio than last year.
2.2 Solvency
- HTA has a Debt/Equity ratio of 0.95. This is a neutral value indicating HTA is somewhat dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC6.43%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. HTA Growth Analysis
3.1 Past
- HTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.54%, which is quite impressive.
- Measured over the past 5 years, HTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.58% on average per year.
- The Revenue has been growing slightly by 4.43% in the past year.
- Measured over the past years, HTA shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y6.58%
EPS Q2Q%-20%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y10.72%
Sales Q2Q%5.48%
3.2 Future
- HTA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.57% yearly.
- Based on estimates for the next years, HTA will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y-3.59%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
EPS Next 5Y9.57%
Revenue Next Year6.57%
Revenue Next 2Y4.52%
Revenue Next 3Y4.63%
Revenue Next 5Y4.05%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. HTA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 69.50 indicates a quite expensive valuation of HTA.
- The average S&P500 Price/Earnings ratio is at 25.60. HTA is valued rather expensively when compared to this.
- HTA is valuated quite expensively with a Price/Forward Earnings ratio of 62.38.
- HTA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.5 | ||
| Fwd PE | 62.38 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.04 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)10.57
EPS Next 2Y3.13%
EPS Next 3Y7.42%
5. HTA Dividend Analysis
5.1 Amount
- HTA has a yearly dividend return of 0.40%, which is pretty low.
- With a Dividend Yield of 0.40, HTA pays less dividend than the S&P500 average, which is at 1.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
- HTA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- HTA pays out 303.50% of its income as dividend. This is not a sustainable payout ratio.
DP303.5%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
HTA Fundamentals: All Metrics, Ratios and Statistics
29.19
-0.02 (-0.07%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-05 2022-05-05/amc
Earnings (Next)08-05 2022-08-05/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.62%
Ins Owner Change0%
Market Cap6.69B
Revenue(TTM)777.58M
Net Income(TTM)94.30M
Analysts71.43
Price Target33.72 (15.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP303.5%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.5 | ||
| Fwd PE | 62.38 | ||
| P/S | 8.6 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.04 |
EPS(TTM)0.42
EY1.44%
EPS(NY)0.47
Fwd EY1.6%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.39
BVpS14.02
TBVpSN/A
PEG (NY)N/A
PEG (5Y)10.57
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.38% | ||
| ROE | 2.94% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 23.13% | ||
| PM (TTM) | 12.13% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score6
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y6.58%
EPS Q2Q%-20%
EPS Next Y-3.59%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
EPS Next 5Y9.57%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y10.72%
Sales Q2Q%5.48%
Revenue Next Year6.57%
Revenue Next 2Y4.52%
Revenue Next 3Y4.63%
Revenue Next 5Y4.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
HEALTHCARE TRUST OF AME-CL A / HTA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEALTHCARE TRUST OF AME-CL A (HTA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to HTA.
Can you provide the valuation status for HEALTHCARE TRUST OF AME-CL A?
ChartMill assigns a valuation rating of 1 / 10 to HEALTHCARE TRUST OF AME-CL A (HTA). This can be considered as Overvalued.
What is the profitability of HTA stock?
HEALTHCARE TRUST OF AME-CL A (HTA) has a profitability rating of 1 / 10.
How financially healthy is HEALTHCARE TRUST OF AME-CL A?
The financial health rating of HEALTHCARE TRUST OF AME-CL A (HTA) is 2 / 10.
How sustainable is the dividend of HEALTHCARE TRUST OF AME-CL A (HTA) stock?
The dividend rating of HEALTHCARE TRUST OF AME-CL A (HTA) is 2 / 10 and the dividend payout ratio is 303.5%.